Evidence map›Paper›PMID 35121971›Full record

ArticleNature cancer2020

Publisher Correction: Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence.

Wiebke Pruessmann, Julie Rytlewski, James Wilmott, Martin C Mihm, Grace H Attrill, Beatrice Dyring-Andersen, Paul Fields, Qian Zhan, Andrew J Colebatch, Peter M Ferguson and 7 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Wiebke Pruessmann *Department of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Julie Rytlewski *Adaptive Biotechnologies, Seattle, WA, USA.ORCID http://orcid.org/0000-0001-5244-6790
James Wilmott *Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-6750-5244
Martin C MihmDepartment of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Grace H AttrillMelanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.
Beatrice Dyring-AndersenDepartment of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Paul FieldsAdaptive Biotechnologies, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-9608-6464
Qian ZhanDepartment of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Andrew J ColebatchMelanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.
Peter M FergusonMelanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.
John F ThompsonMelanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-2816-2496
Klaus KallenbachDepartment of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
Erik YuskoAdaptive Biotechnologies, Seattle, WA, USA.
Rachael A ClarkDepartment of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Harlan RobinsAdaptive Biotechnologies, Seattle, WA, USA.
Richard A Scolyer *Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.ORCID http://orcid.org/0000-0002-8991-0013
Thomas S Kupper *Department of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. tkupper@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-4229-2916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35121971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.